While the recent Food and Drug Administration (FDA) approval of resmetirom for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and liver fibrosis marks a significant milestone, the complex nature of MASLD necessitates a broader range of effective therapeutic strategies [10]
Jastreboff and colleagues, in the New England Journal of Medicine, reported that 48 weeks of treatment cut body weight by 8.7 percent at 1 mg, 17.1 percent at 4 mg, 22.8 percent at 8 mg, and 24.2 percent at 12 mg, all once a week under the skin
Oral semaglutide (Novo Nordisk): GLP-1 only
No, you cannot microdose without a prescription
Quick Answer: Semaglutide and Adderall have no clinically significant drug interaction, but both suppress appetite and affect cardiovascular function, requiring medical monitoring when used together
Nausea, a common early side effect, peaks around days two through five but usually resolves as the body adapts